Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.4K
The pathophysiology of pneumonia involves the following steps:
2.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

656
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
656
Pneumonia IV: Management01:28

Pneumonia IV: Management

690
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
690
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

3.3K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

720
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
720
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

2.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical utility of bronchoalveolar lavage galactomannan result stewardship within a tertiary medical system.

Medical mycology·2026
Same author

Allelic Variations in Genes Modulating Immune Function: Impact on Infections in Organ Transplantation.

The Journal of infectious diseases·2026
Same author

Vatican Revisits Ethics and Science of Xenotransplantation as Clinical Trials Advance.

The Linacre quarterly·2026
Same author

Vatican Reaffirms Moral Permissibility of Xenotransplantation.

Xenotransplantation·2026
Same author

Perspectives on the 2026 ISHLT Consensus Statement on Clinical Cardiac Xenotransplantation.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Integrative analysis of swine infectious diseases in the context of xenotransplantation.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: Dec 29, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

787

Pneumocystis jiroveci.

Jay A Fishman1,2,3

  • 1Department of Medicine, Harvard Medical School, Boston, Massachusetts.

Seminars in Respiratory and Critical Care Medicine
|January 31, 2020
PubMed
Summary
This summary is machine-generated.

Pneumocystis pneumonia (PJP) is a serious fungal infection in immunocompromised individuals, often occurring after transplantation or with prolonged immunosuppression. Early diagnosis and treatment with trimethoprim-sulfamethoxazole are crucial for effective management.

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.5K

Related Experiment Videos

Last Updated: Dec 29, 2025

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
03:22

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE

Published on: March 1, 2024

787
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.5K
Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
07:25

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients

Published on: July 16, 2020

3.5K

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunocompromised Host Pathogens

Background:

  • Pneumocystis jiroveci is a significant fungal pathogen affecting immunocompromised individuals.
  • The reservoir and transmission routes of P. jiroveci remain largely unknown.
  • Pneumocystis pneumonia (PJP) is common post-transplant and during intense immunosuppression, particularly with corticosteroids.

Purpose of the Study:

  • To review the epidemiology, clinical presentation, diagnosis, and management of Pneumocystis pneumonia (PJP).
  • To highlight diagnostic challenges and therapeutic strategies for PJP in immunocompromised patients.

Main Methods:

  • Review of clinical presentations, diagnostic methods, and treatment guidelines for PJP.
  • Discussion of risk factors including organ transplantation, immunosuppression, neutropenia, and hypogammaglobulinemia.
  • Emphasis on diagnostic tools such as CT scans, laboratory markers (LDH, β-D-glucan), and direct immunofluorescence staining.

Main Results:

  • PJP typically presents with fever, dyspnea, hypoxemia, and nonproductive cough.
  • Diagnosis relies on respiratory specimens, with CT scans and laboratory assays aiding detection.
  • Trimethoprim-sulfamethoxazole (TMP-SMX) is the primary treatment, with adjunctive corticosteroids potentially beneficial.

Conclusions:

  • PJP is a critical opportunistic infection requiring prompt diagnosis and treatment.
  • Prophylaxis is recommended for high-risk immunocompromised individuals.
  • Careful management of immunosuppression and prompt therapy are key to improving outcomes.